Differences in E2F subunit expression in quiescent and proliferating vascular smooth muscle cells.

Area of Science:

• Molecular Biology
• Cell Biology
• Cardiovascular Research

Background:

• E2F transcription factors regulate the cell cycle, particularly the G1/S transition.
• Vascular smooth muscle cells (VSMC) are crucial for vascular function and can undergo hypertrophy or hyperplasia.
• Understanding VSMC responses to different stimuli is vital for cardiovascular health.

Purpose of the Study:

• To compare the effects of fetal bovine serum (FBS) and vasoconstrictive hormones on E2F family expression and activity in VSMC.
• To elucidate the mechanisms by which E2F proteins mediate VSMC responses to distinct stimuli.
• To determine the role of E2F in regulating cell cycle progression in VSMC.

Main Methods:

• Quantitative analysis of E2F-1, E2F-3, and E2F-5 mRNA and protein levels.
• Assessment of E2F binding to the E2F-1 promoter.
• Investigation of cdc6 gene transcription and p130 regulation.
• Comparison of VSMC responses to FBS and vasoconstrictive hormones like Angiotensin II (ANG II).

Main Results:

• FBS upregulated E2F-1 and E2F-5 mRNA and protein, while slightly decreasing E2F-3 protein.
• ANG II and arginine vasopressin increased E2F-3 protein without altering its mRNA or affecting E2F-1/E2F-5 levels.
• FBS transactivated the E2F-1 promoter via E2F-1 binding; ANG II-induced E2F-3 binding did not activate the E2F-1 promoter.
• Both FBS and vasoconstrictive hormones promoted cdc6 gene transcription, involving p130 downregulation and E2F-3 recruitment, leading to VSMC S-phase entry.

Conclusions:

• E2F family members exhibit differential regulation by FBS and vasoconstrictive hormones in VSMC.
• Distinct E2F profiles contribute to the hypertrophic/hyperplastic responses of VSMC to various stimuli.
• E2F-3 plays a key role in mediating VSMC cell cycle progression into S phase under both FBS and hormonal stimulation.